Citigroup Inc. reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 11.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 151,284 shares of the medical instruments supplier’s stock after selling 18,626 shares during the period. Citigroup Inc.’s holdings in DENTSPLY SIRONA were worth $4,817,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. MetLife Investment Management LLC increased its holdings in DENTSPLY SIRONA by 23.1% during the 1st quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock worth $2,926,000 after purchasing an additional 11,156 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in DENTSPLY SIRONA by 6.6% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock worth $1,440,000 after purchasing an additional 1,811 shares in the last quarter. Raymond James Trust N.A. increased its holdings in DENTSPLY SIRONA by 61.7% during the 1st quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 2,687 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of DENTSPLY SIRONA by 6.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after acquiring an additional 117,571 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in shares of DENTSPLY SIRONA by 18.9% in the first quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock valued at $23,090,000 after acquiring an additional 74,629 shares in the last quarter. 98.52% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have recently issued reports on XRAY shares. Robert W. Baird upped their target price on DENTSPLY SIRONA from $36.00 to $46.00 in a report on Thursday, May 4th. StockNews.com started coverage on DENTSPLY SIRONA in a report on Thursday. They issued a “buy” rating for the company. Piper Sandler upped their target price on DENTSPLY SIRONA from $29.00 to $35.00 and gave the company a “neutral” rating in a report on Monday, February 6th. The Goldman Sachs Group upped their target price on DENTSPLY SIRONA from $34.00 to $39.00 and gave the company a “neutral” rating in a report on Wednesday, March 1st. Finally, TheStreet raised DENTSPLY SIRONA from a “d+” rating to a “c” rating in a report on Tuesday, February 28th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and a consensus price target of $42.13.
DENTSPLY SIRONA Stock Performance
NASDAQ:XRAY opened at $40.19 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.93. The business has a fifty day simple moving average of $39.76 and a two-hundred day simple moving average of $35.80. DENTSPLY SIRONA Inc. has a 1 year low of $26.48 and a 1 year high of $43.24. The company has a market capitalization of $8.54 billion, a P/E ratio of 15.17, a P/E/G ratio of 2.32 and a beta of 0.91.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.05. The company had revenue of $978.00 million during the quarter, compared to analysts’ expectations of $938.16 million. DENTSPLY SIRONA had a positive return on equity of 8.65% and a negative net margin of 26.41%. The firm’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.52 earnings per share. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current year.
DENTSPLY SIRONA Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, April 14th. Stockholders of record on Friday, March 31st were given a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 1.24%. The ex-dividend date was Thursday, March 30th.
About DENTSPLY SIRONA
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.